Tanya Siddiqi

27PUBLICATIONS
161CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Applied statisticsHaematological tumoursNanomedicineMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (27)

|Jul 28, 2026
Lisocabtagene maraleucel combined with ibrutinib in R/R CLL or SLL: primary results from TRANSCEND CLL 004.

|Jun 04, 2026
Five-year survival outcomes of lisocabtagene maraleucel in R/R LBCL from the TRANSCEND NHL 001 study.

|Apr 16, 2025
International consensus statement on diagnosis, evaluation, and research of Richter transformation: the ERIC recommendations.

Adam S Kittai, Monia Marchetti, Othman Al-Sawaf

|Apr 19, 2024
Acalabrutinib-based regimens in frontline or relapsed/refractory higher-risk CLL: pooled analysis of 5 clinical trials.

Matthew S Davids, Jeff P Sharman, Paolo Ghia

|Mar 29, 2024
Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy for Richter Transformation: An International, Multicenter, Retrospective Study.

Adam S Kittai, David Bond, Ying Huang

|Feb 05, 2024
Biomarker analysis of the ASPEN study comparing zanubrutinib with ibrutinib for patients with Waldenström macroglobulinemia.

Constantine S Tam, Stephen Opat, Shirley D'Sa

Pageof 5

Frequent Collaborators

5 joint publications

Constantine S Tam

5 joint publications

Paolo Ghia

4 joint publications

Ken Ogasawara

4 joint publications

William Wierda